|
C6ORF186 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.509790E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.357900E-04 |
| Normal-vs-Stage2 |
1.153780E-01 |
| Normal-vs-Stage3 |
6.069400E-01 |
| Normal-vs-Stage4 |
1.114790E-01 |
| Stage1-vs-Stage2 |
3.683400E-01 |
| Stage1-vs-Stage3 |
2.687400E-01 |
| Stage1-vs-Stage4 |
7.266400E-01 |
| Stage2-vs-Stage3 |
3.883800E-01 |
| Stage2-vs-Stage4 |
7.522000E-01 |
| Stage3-vs-Stage4 |
3.457200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.824100E-02 |
| Normal-vs-AfricanAmerican |
4.655700E-03 |
| Normal-vs-Asian |
3.177900E-02 |
| Caucasian-vs-AfricanAmerican |
3.680200E-01 |
| Caucasian-vs-Asian |
3.380600E-01 |
| AfricanAmerican-vs-Asian |
6.579000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.79589999999208E-06 |
| Normal-vs-Female |
4.051000E-01 |
| Male-vs-Female |
9.957900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.242000E-01 |
| Normal-vs-Extreme_Weight |
8.045500E-04 |
| Normal-vs-Obese |
2.248300E-02 |
| Normal-vs-Extreme_Obese |
2.217200E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.680420E-01 |
| Normal_Weight-vs-Obese |
3.088800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.216160E-01 |
| Extreme_Weight-vs-Obese |
1.668570E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.563000E-01 |
| Obese-vs-Extreme_Obese |
1.076970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.097690E-03 |
| Normal-vs-Age(41-60Yrs) |
7.043800E-02 |
| Normal-vs-Age(61-80Yrs) |
6.081700E-02 |
| Normal-vs-Age(81-100Yrs) |
8.596500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.942100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.282600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.182400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.111600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.578200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.920400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.201700E-04 |
| Normal-VS-Type2 PRCC |
8.666600E-01 |
| Normal-VS-KIRP CIMP |
2.44410003347184E-09 |
| Normal-VS-Unclassified PRCC |
1.298150E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.298650E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.3280000000534E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
1.366630E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.440900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.775600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.608850E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.043000E-04 |
| Normal-vs-N1 |
5.958800E-01 |
| Normal-vs-N2 |
9.967200E-01 |
| N0-vs-N1 |
3.179400E-01 |
| N0-vs-N2 |
1.504200E-01 |
| N1-vs-N2 |
6.317200E-01 |
|
|
